ArticleInternational journal of reproductive biomedicine2022

Metformin as a potential agent for modulating the faulty endometriotic mesenchymal stem cells: A case-control study.

Parisa Mashayekhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.